Bio-Techne

Business

Bio-Techne Faces Earnings Test Amid Sector Headwinds

Bio-Techne prepares to report quarterly earnings against a backdrop of declining revenue projections and mixed performances from life sciences peers.

Business

Bio-Techne's Synthetic Hydrogel Launch Sparks Investor Interest Amid Mixed Long-Term Performance

Bio-Techne (TECH) gains market attention with the launch of its Cultrex Synthetic Hydrogel, a key innovation for 3D cell research. While the product debut coincides with recent share price strength, longer-term returns tell a more complex story for investors.